Pediatric Clinical Endpoint and Pharmacodynamic Biomarkers: Limitations and Opportunities

Volume: 22, Issue: 1, Pages: 55 - 71
Published: Jan 9, 2020
Abstract
Medical research in children typically lags behind that of adult research in both quantity and quality. The conduct of rigorous clinical trials in children can raise ethical concerns because of children's status as a 'vulnerable' population. Moreover, carrying out studies in pediatrics also requires logistical considerations that rarely occur with adult clinical trials. Due to the relatively smaller number of pediatric studies to support...
Paper Details
Title
Pediatric Clinical Endpoint and Pharmacodynamic Biomarkers: Limitations and Opportunities
Published Date
Jan 9, 2020
Volume
22
Issue
1
Pages
55 - 71
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.